EAACI Congress 2025
BackTPS67 - Biologicals 03
Sunday 15 Jun, 12:45 PM -
13:45 PM Glasgow, United Kingdom
10:45 AM - 11:45 AM Your local time
10:45 AM - 11:45 AM Your local time
Poster Zone
Thematic Poster Session
Analysis of discontinuation of omalizumab in patients with chronic spontaneous and/or inducible urticaria in a tertiary hospital in one year
Dupilumab: Real-Life Effectiveness, Safety, and Impact on Type 2 and Non-Type 2 Comorbidities in Atopic Dermatitis Across Paediatric, Adolescent, and Adult Patients in Argentina – A 5-Year Review
Effect of Omalizumab on Inflammatory and Immune Biomarkers in Mast Cell-Mediated Angioedema
Exploring potential predictive factors for time to response to Omalizumab treatment in a Romanian subset of patients with Chronic Spontaneous Urticaria
Mental health, sexual functionality, quality of life, and patient experiences with chronic rhinosinusitis with nasal polyps at UNIMEQ-ORL in Bogotá, Colombia, 2022-2024: a mixed-methods study
Study of olfaction in patients with chronic rhinosinusitis with nasal polyposis undergoing Mepolizumab treatment
The impact of limited access to On-Demand Treatment for Hereditary Angioedema on Quality of life: a comparison between two income settings
The role of anosmia in predicting biologic responsiveness for Chronic Rhinosinusitis with Nasal Polyposis
Use and safety of canakinumab during pregnancy
Vitamin D3 deficiency promotes epithelial-to-mesenchymal transition and thus favours pulmonary fibrosis development in the murine model of hypersensitivity pneumonitis
